Phosphonoacetic Acid → N-[1-benzyloxycarbonyl-2-(1H-indol-3-yl)-ethyl]-3-[2-(diethoxy-phosphoryl)4-phenyl-butyrylamino]-succinamic acid benzyl ester

HRID 2214283Notizen

Reaktionsgleichung

Reaktionsgleichung von HRID 2214283
[CH2:1]([O:8][C:9](=[O:37])[CH2:10][CH:11]([NH2:36])[C:12]([NH:14][CH:15]([C:26]([O:28][CH2:29][C:30]1[CH:35]=[CH:34][CH:33]=[CH:32][CH:31]=1)=[O:27])[CH2:16][C:17]1[C:25]2[C:20](=[CH:21][CH:22]=[CH:23][CH:24]=2)[NH:19][CH:18]=1)=[O:13])[C:2]1[CH:7]=[CH:6][CH:5]=[CH:4][CH:3]=1.[P:38]([CH2:42][C:43](O)=O)([OH:41])([OH:40])=[O:39].[CH:46]1[CH:47]=[CH:48][C:49]2N(O)N=N[C:50]=2[CH:51]=1.[CH2:56]1CN([P+](ON2N=NC3C=CC=CC2=3)(N2CCCC2)N2CCCC2)C[CH2:57]1.F[P-](F)(F)(F)(F)F.[CH3:89][CH2:90]N(C(C)C)C(C)C.[C:98]([O-:101])(O)=O.[Na+].[CH3:103]N(C=O)C>C(OCC)(=O)C.C(OCC)(=O)C.CCCCCC>[CH2:1]([O:8][C:9](=[O:37])[CH2:10][CH:11]([NH:36][C:98](=[O:101])[CH:42]([P:38]([O:41][CH2:89][CH3:90])([O:40][CH2:56][CH3:57])=[O:39])[CH2:43][CH2:103][C:50]1[CH:49]=[CH:48][CH:47]=[CH:46][CH:51]=1)[C:12]([NH:14][CH:15]([C:26]([O:28][CH2:29][C:30]1[CH:31]=[CH:32][CH:33]=[CH:34][CH:35]=1)=[O:27])[CH2:16][C:17]1[C:25]2[C:20](=[CH:21][CH:22]=[CH:23][CH:24]=2)[NH:19][CH:18]=1)=[O:13])[C:2]1[CH:7]=[CH:6][CH:5]=[CH:4][CH:3]=1

Komponenten

10

Versuchsvorschrift

To a stirred solution of the peptide of Example 83 (536 mg, 1.00 mmol) in DMF (3 mL) was sequentially added phosphonoacetic acid 79 (1.00 mmol), HOBt (135 mg, 1.00 mmol) and PYBOP (520 mg, 1.00 mmol) at room temperature. DIPEA (523 μL, 3.00 mmol) was then added and the mixture was stirred at room temperature for 18 h. The reaction mixture was poured onto an aqueous solution of NaHCO3 (5%) and extracted several times with ethyl acetate. The combined organic extracts were washed with NaHCO3 (5%), H2O, KHSO4 (5%) and H2O. Drying (Na2SO4) and evaporation gave the crude product (780 mg) as a light oil. Flash chromatography (SiO2, ethyl acetate:hexane (2:1) to 100% ethyl acetate) gave a separable pair of diastereoisomers in a combined yield of 71%. The less polar diastereoisomer had the following spectroscopic data: 1H NMR (CDCl3, 400 MHz) □ 8.03 (br d, 2H), 7.61 (br d, 1H), 7.40–7.11 (m, 19H), 6.82 (d, 1H), 5.15–4.82 (m, 5H), 4.87 (dd, 1H), 4.01 (m, 4H), 3.31 (d, 2H), 3.08 (dd, 1H), 2.78–2.43 (m, 4H), 2.35 (m, 1H), 2.00 (m, 1H), 1.26 (dt, 6H); 31P NMR (CDCl3) δ 25.1; MS (Pos. FAB) 780.8 (M+).

Aufarbeitung

  1. customat room temperature
  2. extractionextracted several times with ethyl acetate
  3. washThe combined organic extracts were washed with NaHCO3 (5%), H2O, KHSO4 (5%) and H2O
  4. customDrying
  5. custom(Na2SO4) and evaporation
  6. customgave the crude product (780 mg) as a light oil

Quellen und Nachweise

ORD-Eintrag
ord-b488b2b170a44980a699225b9b880247
Quelldatensatz
uspto-grants-2006_09
Patentnummer
US07105539B2

Notizen zur Reaktion

Wird geladen…